Inclusiveness: pharmaceuticals
| Quick info | |
|---|---|
| Data type | String |
| Scale | Categorical |
| Value labels | NA (no information available) |
| Technical name | health_hc_djgen_incl_pharmaceuticals |
| Category | Health and long-term care |
| Label | Inclusiveness: pharmaceuticals |
| Related indicators | NA (no information available) |
This indicator provides the specific social groups that are entitled to access pharmaceuticals by legislative texts. The variable is coded following the Art.13 of the Medical Care and Sickness Benefits Convention (1969) of the International Labor Organization –ILO–, which establishes the categories of services that medical care must comprise. This indicator is defined as pharmaceuticals as in subsection (c) of the mentioned article.
Coding rules
The variable is coded following the Art.13 of the Medical Care and Sickness Benefits Convention (1969) of the International Labor Organization –ILO–, which establishes the categories of services that medical care must comprise. This indicator is defined as pharmaceuticals as in subsection (c) of the mentioned article encompassing the following codes: pharmaceuticals.
The code pharmaceuticals (312) refers to “Medicines and other medical goods are frequently a component of a package of services with a preventive, curative, rehabilitative or long-term care purpose.” (OECD System of Health Accounts, p. 97). The code “pharmaceuticals” refers to “pharmaceutical products and non-durable medical goods intended for use in the diagnosis, cure, mitigation or treatment of disease” (OECD System of Health Accounts, p. 97) prescribed by physicians or other qualified health personnel and dispensed in pharmacies.
Bibliographic info
Citation: Codebook (in publication)
Related publications: NA (no information available)
Misc
Project manager(s): Alexander Polte; Matías Acosta; Mai Mahmoud
Data release: 31.10.2024
Revisions: NA (no information available)
Sources
National legislation
